clomiphene therapy pregnancy outcome birth defects, clomiphene citrate congenital malformations risk, ovulation induction drug safety pregnancy outcomes, clomiphene twin pregnancy rate incidence, birth defects after drug induced ovulation subfertility, clomiphene pregnancy malformation rate gonadotropin comparison, Ahlgren Källén clomiphene pregnancy outcome, subfertility underlying cause congenital malformations, clomiphene citrate 159 pregnancies childbirth outcomes, ovulation induction teratogenicity assessment
Keywords
Abnormalities, Drug-Induced, Anovulation/drug Therapy, Clomiphene/adverse Effects/therapeutic Use, Female, Humans, Pregnancy, Pregnancy Complications/chemically Induced, Pregnancy, Multiple, Teratogens, Twins, Teratogens, Clomiphene, Abortion, Spontaneous, Clomiphene--administraction and Dosage, Clomiphene--side Effects, Clomiphene--therapeutic Use, Congenital Abnormalities, Diseases, Family Planning, Fertility Agents, Gonadotropins, Gonadotropins, Chorionic, Incidence, Maternal Age, Measurement, Neonatal Diseases And Abnormalities, Pregnancy, Multiple, Reproductive Control Agents, Research Methodology